← Open Payments lookup

RYAN ROSEBROUGH: Open Payments

NPI 1487027058 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,076 in 91 payments from 19 companies in 2025. Trend: 2023 $1,553 · 2024 $1,989 · 2025 $2,076

Food & beverage: $2,076
CompanyPaymentsAmount
ABBVIE INC.38$895
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$145
Janssen Biotech, Inc.7$142
NeurAxis, Inc.1$136
Takeda Pharmaceuticals U.S.A., Inc.6$121
Ardelyx, Inc.6$106
Novo Nordisk Inc4$91
Regeneron Healthcare Solutions, Inc.4$82
Ipsen Biopharmaceuticals, Inc3$57
PFIZER INC.3$54

Products named: RINVOQ, XIFAXAN, TREMFYA, CREON, DUPIXENT, SKYRIZI, IBSRELA, ENTYVIO.

Industry payments across IN — which companies pay providers there.